Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nikolaus Schultz

Showing results (31-40 of 320) with videos related to

Pageof 32
Sort By:
Targeted Oncology|September 17, 2022
Effect of FGFR2 Alterations on Overall and Progression-Free Survival in Patients Receiving Systemic Therapy for Intrahepatic CholangiocarcinomaGhassan K Abou-Alfa, Kristen Bibeau, Nikolaus Schultz, et al.
JCO Precision Oncology|February 2, 2022
Distinct Genomic Landscapes in Early-Onset and Late-Onset Endometrial CancerJungyoon Choi, Andreana N Holowatyj, Mengmeng Du, et al.
Nucleic Acids Research|November 22, 2015
MutationAligner: a resource of recurrent mutation hotspots in protein domains in cancerNicholas Paul Gauthier, Ed Reznik, Jianjiong Gao, et al.
Molecular Cancer Therapeutics|March 5, 2022
Optimal Strategy and Benefit of Pulsed Therapy Depend On Tumor Heterogeneity and Aggressiveness at Time of Treatment InitiationDeepti Mathur, Bradford P Taylor, Walid K Chatila, et al.
Plos One|April 28, 2012
Integrative subtype discovery in glioblastoma using iClusterRonglai Shen, Qianxing Mo, Nikolaus Schultz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 15, 2024
Retraction: Chemotherapy Resistance in Diffuse-Type Gastric Adenocarcinoma Is Mediated by RhoA Activation in Cancer Stem-Like CellsChanghwan Yoon, Soo-Jeong Cho, Bülent Arman Aksoy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 21, 2015
RETRACTED: Chemotherapy Resistance in Diffuse-Type Gastric Adenocarcinoma Is Mediated by RhoA Activation in Cancer Stem-Like CellsChanghwan Yoon, Soo-Jeong Cho, Bülent Arman Aksoy, et al.
Breast Cancer Research and Treatment|October 8, 2013
The molecular diversity of Luminal A breast tumorsGiovanni Ciriello, Rileen Sinha, Katherine A Hoadley, et al.
Developmental Biology|April 28, 2004
Defining the spermatogonial stem cellF Kent Hamra, Nikolaus Schultz, Karen M Chapman, et al.
Research Square|July 28, 2023
Cooperative Genomic Lesions in HRAS-Mutant Cancers Predict Resistance to Farnesyltransferase InhibitorsAradhya Nigam, Gnana Krishnamoorthy, Walid Chatila, et al.
Pageof 32

Showing results (31-40 of 320) with videos related to

Sort By:
Pageof 32
Targeted Oncology|September 17, 2022
Effect of FGFR2 Alterations on Overall and Progression-Free Survival in Patients Receiving Systemic Therapy for Intrahepatic CholangiocarcinomaGhassan K Abou-Alfa, Kristen Bibeau, Nikolaus Schultz, et al.
JCO Precision Oncology|February 2, 2022
Distinct Genomic Landscapes in Early-Onset and Late-Onset Endometrial CancerJungyoon Choi, Andreana N Holowatyj, Mengmeng Du, et al.
Nucleic Acids Research|November 22, 2015
MutationAligner: a resource of recurrent mutation hotspots in protein domains in cancerNicholas Paul Gauthier, Ed Reznik, Jianjiong Gao, et al.
Molecular Cancer Therapeutics|March 5, 2022
Optimal Strategy and Benefit of Pulsed Therapy Depend On Tumor Heterogeneity and Aggressiveness at Time of Treatment InitiationDeepti Mathur, Bradford P Taylor, Walid K Chatila, et al.
Plos One|April 28, 2012
Integrative subtype discovery in glioblastoma using iClusterRonglai Shen, Qianxing Mo, Nikolaus Schultz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 15, 2024
Retraction: Chemotherapy Resistance in Diffuse-Type Gastric Adenocarcinoma Is Mediated by RhoA Activation in Cancer Stem-Like CellsChanghwan Yoon, Soo-Jeong Cho, Bülent Arman Aksoy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 21, 2015
RETRACTED: Chemotherapy Resistance in Diffuse-Type Gastric Adenocarcinoma Is Mediated by RhoA Activation in Cancer Stem-Like CellsChanghwan Yoon, Soo-Jeong Cho, Bülent Arman Aksoy, et al.
Breast Cancer Research and Treatment|October 8, 2013
The molecular diversity of Luminal A breast tumorsGiovanni Ciriello, Rileen Sinha, Katherine A Hoadley, et al.
Developmental Biology|April 28, 2004
Defining the spermatogonial stem cellF Kent Hamra, Nikolaus Schultz, Karen M Chapman, et al.
Research Square|July 28, 2023
Cooperative Genomic Lesions in HRAS-Mutant Cancers Predict Resistance to Farnesyltransferase InhibitorsAradhya Nigam, Gnana Krishnamoorthy, Walid Chatila, et al.
Pageof 32